EMTRIVA Side Effects

6880054-3 | Congenital Tricuspid Valve Atresia, Hypoplastic Right Heart Syndrome
on Jul 19, 2010 Female patient from UNITED STATES , weighting 7.02 lb, was diagnosed with prophylaxis against hiv infection (What is prophylaxis against hiv infection?) and was treated with Emtriva (View Usage). Patient experienced the following unwanted or unexpected effects: congenital tricuspid valve atresia, hypoplastic right heart syndrome. Emtriva dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), RETROVIR (View Retrovir Review and Retrovir Label ).

6595153-3 | Congenital Tricuspid Valve Atresia, Hypoplastic Right Heart Syndrome
Patient was taking Emtriva (View Usage). Patient had the following side effects: congenital tricuspid valve atresia, hypoplastic right heart syndrome on Feb 04, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 7.02 lb, . Emtriva dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6580740-9 | Congenital Tricuspid Valve Atresia, Hypoplastic Right Heart Syndrome
Adverse event was reported on Feb 04, 2010 by a Female patient taking Emtriva (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 7.02 lb, After Emtriva was administered, patient had the following side effects: congenital tricuspid valve atresia, hypoplastic right heart syndrome. During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).

6567605-3 | Congenital Tricuspid Valve Atresia, Hypoplastic Right Heart Syndrome
on Jan 21, 2010 Female patient from UNITED STATES , weighting 7.02 lb, was treated with Emtriva (View Usage). Patient experienced the following unwanted or unexpected effects: congenital tricuspid valve atresia, hypoplastic right heart syndrome. Emtriva dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ).


6474826-7 | Dizziness, Nervous System Disorder, Sleep Disorder
on Nov 24, 2009 Male patient from UNITED KINGDOM , 32 years of age, weighting 172.0 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtriva (View Usage). Patient had the following side effects: dizziness (What is dizziness?), nervous system disorder, sleep disorder (What is sleep disorder?). Emtriva dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), SUSTIVA (View Sustiva Review and Sustiva Label ), CO TRIMOXAZOLE (View Co-trimoxazole Review and Co-trimoxazole Label ).

6411233-7 | Abortion Spontaneous
Patient was taking Emtriva (View Usage). After Emtriva was administered, patient had the following side effects: abortion spontaneous on Oct 19, 2009 from UNITED STATES Additional patient health information: Female patient , 43 years of age, was diagnosed with hiv infection (What is hiv infection?), hypertension and. Emtriva dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), KALETRA (View Kaletra Review and Kaletra Label ), RETROVIR (View Retrovir Review and Retrovir Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), BACTRIM (View Bactrim Review and Bactrim Label ), MODURETIC 5 50 (View Moduretic 5-50 Review and Moduretic 5-50 Label ).

6358527-1 | Acne, Blood Hiv Rna Increased, Dermatitis Acneiform, Exfoliative Rash, Immune Reconstitution Syndrome, Rash Erythematous, Rebound Effect, Toxic Epidermal Necrolysis
Adverse event was reported on Sep 01, 2009 by a Female patient taking Emtriva (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED KINGDOM , 33 years of age, Patient experienced the following unwanted or unexpected effects: acne (What is acne?), blood hiv rna increased (What is blood hiv rna increased?), dermatitis acneiform, exfoliative rash, immune reconstitution syndrome, rash erythematous, rebound effect, toxic epidermal necrolysis. During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ). Patient was hospitalized.

6207739-6 | Dehydration, Renal Failure Acute, Urinary Tract Infection
on May 20, 2009 Male patient from MEXICO , 45 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtriva (View Usage). Patient had the following side effects: dehydration, renal failure acute, urinary tract infection (What is urinary tract infection?). Emtriva dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), TIPRANAVIR (View Tipranavir Review and Tipranavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ). Patient was hospitalized.

6188473-8 | Placental Disorder, Stillbirth
on May 01, 2009 Female patient from UNITED STATES , 21 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtriva (View Usage). After Emtriva was administered, patient had the following side effects: placental disorder, stillbirth. Emtriva dosage: . During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), KALETRA (View Kaletra Review and Kaletra Label ).

6177058-5 | Confusional State
Patient was taking Emtriva (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state on Apr 23, 2009 from UNITED STATES Additional patient health information: Male patient , 47 years of age, weighting 145.7 lb, was diagnosed with hiv infection (What is hiv infection?), tuberculosis (What is tuberculosis?), convulsion and. Emtriva dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), SUSTIVA (View Sustiva Review and Sustiva Label ), RIFAFOUR (View Rifafour Review and Rifafour Label ), PYRIDOXINE (View Pyridoxine Review and Pyridoxine Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), BACTRIM (View Bactrim Review and Bactrim Label ). Patient was hospitalized.

6159431-4 | Pancreatitis Relapsing
Adverse event was reported on Apr 10, 2009 by a Male patient taking Emtriva (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , weighting 130.1 lb, Patient had the following side effects: pancreatitis relapsing. During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), REYATAZ (View Reyataz Review and Reyataz Label ), FUZEON (View Fuzeon Review and Fuzeon Label ), FLUTICASONE (View Fluticasone Review and Fluticasone Label ), CETIRIZINE HYDROCHLORIDE (View Cetirizine Hydrochloride Review and Cetirizine Hydrochloride Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), OXANDROLONE (View Oxandrolone Review and Oxandrolone Label ). Patient was hospitalized.

6102235-9 | Abortion Induced, Pregnancy
on Feb 20, 2009 Female patient from FRANCE , 25 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtriva (View Usage). After Emtriva was administered, patient had the following side effects: abortion induced, pregnancy (What is pregnancy?). Emtriva dosage: . During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), KALETRA (View Kaletra Review and Kaletra Label ), COMBIVIR (View Combivir Review and Combivir Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ).

6065380-2 | Pre-eclampsia
on Jan 29, 2009 Female patient from UNITED STATES , 35 years of age, weighting 147.7 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtriva (View Usage). Patient experienced the following unwanted or unexpected effects: pre-eclampsia. Emtriva dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), CETIRIZINE (View Cetirizine Review and Cetirizine Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ). Patient was hospitalized.

6047208-X | Stillbirth
Patient was taking Emtriva (View Usage). Patient had the following side effects: stillbirth on Jan 13, 2009 from UNITED STATES Additional patient health information: Female patient , 21 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Emtriva dosage: . During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), KALETRA (View Kaletra Review and Kaletra Label ).

6035171-7 | Pre-eclampsia
Adverse event was reported on Jan 08, 2009 by a Female patient taking Emtriva (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 35 years of age, weighting 147.7 lb, After Emtriva was administered, patient had the following side effects: pre-eclampsia. During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ), ASCORBIC ACID (View Ascorbic Acid Review and Ascorbic Acid Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ). Patient was hospitalized.

6018778-2 | Stillbirth
on Dec 18, 2008 Female patient from UNITED STATES , 21 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtriva (View Usage). Patient experienced the following unwanted or unexpected effects: stillbirth. Emtriva dosage: . During the same period patient was treated with ZIDOVUDINE (View Zidovudine Review and Zidovudine Label ), KALETRA (View Kaletra Review and Kaletra Label ).

5915849-3 | Abortion Spontaneous
on Oct 07, 2008 Female patient from UNITED STATES , 43 years of age, was diagnosed with hiv infection (What is hiv infection?), hypertension and was treated with Emtriva (View Usage). Patient had the following side effects: abortion spontaneous. Emtriva dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), KALETRA (View Kaletra Review and Kaletra Label ), RETROVIR (View Retrovir Review and Retrovir Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), BACTRIM (View Bactrim Review and Bactrim Label ), MODURETIC 5 50 (View Moduretic 5-50 Review and Moduretic 5-50 Label ).

5908943-4 | Acne, Blood Hiv Rna Increased, Dermatitis Acneiform, Exfoliative Rash, Immune Reconstitution Syndrome, Rash Erythematous, Rebound Effect, Toxic Epidermal Necrolysis
Patient was taking Emtriva (View Usage). After Emtriva was administered, patient had the following side effects: acne (What is acne?), blood hiv rna increased (What is blood hiv rna increased?), dermatitis acneiform, exfoliative rash, immune reconstitution syndrome, rash erythematous, rebound effect, toxic epidermal necrolysis on Sep 29, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 33 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Emtriva dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ). Patient was hospitalized.

5902366-X | Acne, Dermatitis Acneiform, Exfoliative Rash, Immune Reconstitution Syndrome, Rash Erythematous, Toxic Epidermal Necrolysis
Adverse event was reported on Sep 23, 2008 by a Female patient taking Emtriva (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED KINGDOM , 33 years of age, Patient experienced the following unwanted or unexpected effects: acne (What is acne?), dermatitis acneiform, exfoliative rash, immune reconstitution syndrome, rash erythematous, toxic epidermal necrolysis. During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ). Patient was hospitalized.

5892247-2 | Hepatitis
on Sep 15, 2008 Female patient from UNITED KINGDOM , 38 years of age, weighting 158.7 lb, was treated with Emtriva (View Usage). Patient had the following side effects: hepatitis (What is hepatitis?). Emtriva dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ).

5890011-1 | Osteomyelitis, Salmonellosis
on Sep 08, 2008 Male patient from UNITED KINGDOM , 44 years of age, was diagnosed with hiv infection (What is hiv infection?), glomerulonephritis, glomerulonephritis membranous and was treated with Emtriva (View Usage). After Emtriva was administered, patient had the following side effects: osteomyelitis, salmonellosis. Emtriva dosage: . During the same period patient was treated with EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), LOPINAVIR (View Lopinavir Review and Lopinavir Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

5888616-7 | Abortion Spontaneous
Patient was taking Emtriva (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous on Sep 11, 2008 from UNITED STATES Additional patient health information: Female patient , 43 years of age, was diagnosed with hiv infection (What is hiv infection?), hypertension and. Emtriva dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), KALETRA (View Kaletra Review and Kaletra Label ), RETROVIR (View Retrovir Review and Retrovir Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), BACTRIM (View Bactrim Review and Bactrim Label ), MODURETIC 5 50 (View Moduretic 5-50 Review and Moduretic 5-50 Label ).

5816848-2 | Blood Creatinine Increased, Creatinine Renal Clearance Decreased
Adverse event was reported on Jul 03, 2008 by a Male patient taking Emtriva (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: SPAIN , 48 years of age, Patient had the following side effects: blood creatinine increased, creatinine renal clearance decreased. During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), ATAZANAVIR (View Atazanavir Review and Atazanavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ).

5783002-2 | Acute Prerenal Failure, Alanine Aminotransferase Increased, Anaemia, Aspartate Aminotransferase Increased, Asthenia, Blood Calcium Decreased, Exfoliative Rash, Fanconi Syndrome, Gastroenteritis
on Jun 19, 2008 Female patient from UNITED STATES , 39 years of age, weighting 93.70 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtriva (View Usage). After Emtriva was administered, patient had the following side effects: acute prerenal failure, alanine aminotransferase increased, anaemia, aspartate aminotransferase increased, asthenia, blood calcium decreased, exfoliative rash, fanconi syndrome, gastroenteritis (What is gastroenteritis?). Emtriva dosage: 200 Mg Qd Oral. During the same period patient was treated with VIRAMUNE (200 Mg Bid Oral) (View Viramune Review and Viramune Label ), VIDEX (250 Mg Qd Oral) (View Videx Review and Videx Label ).

5694096-7 | Abortion Spontaneous
on Apr 01, 2008 Female patient from UNITED STATES , 28 years of age, weighting 108.9 lb, was diagnosed with hiv infection (What is hiv infection?), pelvic inflammatory disease (What is pelvic inflammatory disease?) and was treated with Emtriva (View Usage). Patient experienced the following unwanted or unexpected effects: abortion spontaneous. Emtriva dosage: . During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ), METRONIDAZOLE HCL (View Metronidazole Hcl Review and Metronidazole Hcl Label ).

5689184-5 | Abortion Spontaneous
Patient was taking Emtriva (View Usage). Patient had the following side effects: abortion spontaneous on Mar 27, 2008 from UNITED STATES Additional patient health information: Female patient , 28 years of age, weighting 108.9 lb, was diagnosed with hiv infection (What is hiv infection?), pelvic inflammatory disease (What is pelvic inflammatory disease?) and. Emtriva dosage: . During the same period patient was treated with DIDANOSINE (View Didanosine Review and Didanosine Label ), ATAZANAVIR SULFATE (View Atazanavir Sulfate Review and Atazanavir Sulfate Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), DOXYCLINE (View Doxycline Review and Doxycline Label ), METRONIDAZOLE HCL (View Metronidazole Hcl Review and Metronidazole Hcl Label ).

5639573-X | Blood Glucose Increased, Lipids Increased, Lipomatosis, Weight Increased
Adverse event was reported on Feb 21, 2008 by a Male patient taking Emtriva (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 50 years of age, After Emtriva was administered, patient had the following side effects: blood glucose increased, lipids increased, lipomatosis, weight increased. During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ).

5631415-1 | Blood Glucose Increased, Lipids Increased, Lipomatosis, Weight Increased
on Feb 15, 2008 Male patient from UNITED STATES , 50 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtriva (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, lipids increased, lipomatosis, weight increased. Emtriva dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ).

5572124-7 | Arthralgia, Fracture
on Dec 18, 2007 Female patient from FRANCE , 45 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtriva (View Usage). Patient had the following side effects: arthralgia, fracture (What is fracture?). Emtriva dosage: . During the same period patient was treated with ZIAGEN (View Ziagen Review and Ziagen Label ), ANSATIPINE (View Ansatipine Review and Ansatipine Label ), ZECLAR (View Zeclar Review and Zeclar Label ), STILNOX (View Stilnox Review and Stilnox Label ). Patient was hospitalized.

5511770-3 | Liver Disorder
Patient was taking Emtriva (View Usage). After Emtriva was administered, patient had the following side effects: liver disorder on Sep 11, 2007 from SWITZERLAND Additional patient health information: Male patient , weighting 167.6 lb, was diagnosed with hiv infection (What is hiv infection?) and. Emtriva dosage: . During the same period patient was treated with VIRAMUNE (View Viramune Review and Viramune Label ), VIREAD (View Viread Review and Viread Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ).

5463312-9 | Blood Creatinine Increased, Dehydration
Adverse event was reported on Sep 11, 2007 by a Male patient taking Emtriva (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: MEXICO , weighting 138.9 lb, Patient experienced the following unwanted or unexpected effects: blood creatinine increased, dehydration. During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), TRIMETHOPRIM + SULFAMETHOXAZOLE (High Dose) (View Trimethoprim + Sulfamethoxazole Review and Trimethoprim + Sulfamethoxazole Label ). Patient was hospitalized.

5450048-3 | Alanine Aminotransferase Increased, Antinuclear Antibody Positive, Bilirubin Conjugated Increased, Blood Bilirubin Increased, Epidermal Necrosis, Haemoglobinaemia, Hair Colour Changes, Lymphoproliferative Disorder
on Sep 03, 2007 Male patient from FRANCE , weighting 165.3 lb, was diagnosed with hiv infection (What is hiv infection?), muscle spasms and was treated with Emtriva (View Usage). Patient had the following side effects: alanine aminotransferase increased, antinuclear antibody positive, bilirubin conjugated increased, blood bilirubin increased, epidermal necrosis, haemoglobinaemia, hair colour changes, lymphoproliferative disorder. Emtriva dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), TRUVADA (View Truvada Review and Truvada Label ), HEXAQUINE (View Hexaquine Review and Hexaquine Label ), NORVIR (View Norvir Review and Norvir Label ), REYATAZ (View Reyataz Review and Reyataz Label ), ZELITREX (View Zelitrex Review and Zelitrex Label ), MIXTARD HUMAN 70/30 (View Mixtard Human 70/30 Review and Mixtard Human 70/30 Label ), ATATRAX (View Atatrax Review and Atatrax Label ). Patient was hospitalized and became disabled.

5439507-7 | Liver Disorder
on Aug 20, 2007 Male patient from SWITZERLAND , weighting 167.6 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtriva (View Usage). After Emtriva was administered, patient had the following side effects: liver disorder. Emtriva dosage: . During the same period patient was treated with VIRAMUNE (View Viramune Review and Viramune Label ), VIREAD (View Viread Review and Viread Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ).

5423883-5 | Blood Creatinine Increased, Blood Urea Increased, Dehydration, Diarrhoea, Nausea
Patient was taking Emtriva (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, blood urea increased, dehydration, diarrhoea, nausea (What is nausea?) on Aug 13, 2007 from MEXICO Additional patient health information: Male patient , weighting 138.9 lb, was diagnosed with hiv infection (What is hiv infection?) and. Emtriva dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), TRIMETHOPRIM + SULFAMETHOXAZOLE (High Dose) (View Trimethoprim + Sulfamethoxazole Review and Trimethoprim + Sulfamethoxazole Label ). Patient was hospitalized.

5418663-0 | Liver Disorder
Adverse event was reported on Aug 07, 2007 by a Male patient taking Emtriva (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: SWITZERLAND , weighting 167.6 lb, Patient had the following side effects: liver disorder. During the same period patient was treated with VIRAMUNE (View Viramune Review and Viramune Label ), VIREAD (View Viread Review and Viread Label ), MORPHINE SULFATE (View Morphine Sulfate Review and Morphine Sulfate Label ).

5392577-7 | Blood Creatine Phosphokinase Increased, Hyperlactacidaemia, Monoparesis, Myositis, Oedema Peripheral
on Oct 09, 2006 Male patient from UNITED KINGDOM , 50 years of age, weighting 143.3 lb, was diagnosed with candidiasis and was treated with Emtriva (View Usage). After Emtriva was administered, patient had the following side effects: blood creatine phosphokinase increased, hyperlactacidaemia, monoparesis, myositis (What is myositis?), oedema peripheral. Emtriva dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), FOSAMPRENAVIR (View Fosamprenavir Review and Fosamprenavir Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ). Patient was hospitalized.

5346481-0 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased
on May 29, 2007 Male patient from SPAIN , 41 years of age, was treated with Emtriva (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased. Emtriva dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), VIRAMUNE (View Viramune Review and Viramune Label ).

5289527-0 | Pancreatitis Acute
Patient was taking Emtriva (View Usage). Patient had the following side effects: pancreatitis acute on Mar 28, 2007 from MEXICO Additional patient health information: Male patient , weighting 119.0 lb, was diagnosed with hiv infection (What is hiv infection?) and. Emtriva dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ). Patient was hospitalized.

5285276-3 | Pre-eclampsia, Pregnancy
Adverse event was reported on Mar 29, 2007 by a Female patient taking Emtriva (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 19 years of age, After Emtriva was administered, patient had the following side effects: pre-eclampsia, pregnancy (What is pregnancy?). During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), RETROVIR (View Retrovir Review and Retrovir Label ), SUSTIVA (View Sustiva Review and Sustiva Label ), TRIZIVIR (View Trizivir Review and Trizivir Label ).

5237913-7 | Pre-eclampsia, Pregnancy
on Feb 02, 2007 Female patient from UNITED STATES , 19 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtriva (View Usage). Patient experienced the following unwanted or unexpected effects: pre-eclampsia, pregnancy (What is pregnancy?). Emtriva dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), RETROVIR (View Retrovir Review and Retrovir Label ), SUSTIVA (View Sustiva Review and Sustiva Label ).

5212230-X | Haemoglobinaemia, Photosensitivity Reaction, Pruritus
on Jan 09, 2007 Male patient from FRANCE , 47 years of age, weighting 169.8 lb, was treated with Emtriva (View Usage). Patient had the following side effects: haemoglobinaemia, photosensitivity reaction, pruritus. Emtriva dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), ZELITREX (View Zelitrex Review and Zelitrex Label ), NORVIR (View Norvir Review and Norvir Label ), REYATAZ (View Reyataz Review and Reyataz Label ), BACLOFENE IREX (View Baclofene Irex Review and Baclofene Irex Label ), MIXTARD HUMAN 70/30 (View Mixtard Human 70/30 Review and Mixtard Human 70/30 Label ), ATATRAX (View Atatrax Review and Atatrax Label ), BACTRIM (View Bactrim Review and Bactrim Label ). Patient was hospitalized.

5212123-8 | Myocardial Infarction
Patient was taking Emtriva (View Usage). After Emtriva was administered, patient had the following side effects: myocardial infarction on Jan 08, 2007 from FRANCE Additional patient health information: Male patient , 53 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Emtriva dosage: . During the same period patient was treated with SUSTIVA (View Sustiva Review and Sustiva Label ), KALETRA (View Kaletra Review and Kaletra Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), TRIATEC (View Triatec Review and Triatec Label ), PLAVIX (View Plavix Review and Plavix Label ), SECTRAL (View Sectral Review and Sectral Label ). Patient was hospitalized.

5168392-6 | Acid Fast Bacilli Infection, Anorexia, Asthenia, Chest Pain, Confusional State, Diarrhoea, Eructation, Haematocrit Decreased, Haemoglobin Decreased
Adverse event was reported on Nov 14, 2006 by a Male patient taking Emtriva (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , 31 years of age, weighting 131.8 lb, Patient experienced the following unwanted or unexpected effects: acid fast bacilli infection, anorexia, asthenia, chest pain (What is chest pain?), confusional state, diarrhoea, eructation, haematocrit decreased, haemoglobin decreased. During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), SUSTIVA (View Sustiva Review and Sustiva Label ), COTRIM D.S. (View Cotrim D.s. Review and Cotrim D.s. Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ). Patient was hospitalized.

5165636-1 | Pancreatitis
on Nov 24, 2006 Male patient from UNITED KINGDOM , 37 years of age, weighting 125.7 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtriva (View Usage). Patient had the following side effects: pancreatitis. Emtriva dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), NORVIR (View Norvir Review and Norvir Label ), TELZIR (View Telzir Review and Telzir Label ). Patient was hospitalized.

5156370-2 | Hepatic Encephalopathy
on Nov 14, 2006 Male patient from UNITED STATES , 31 years of age, weighting 131.8 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtriva (View Usage). After Emtriva was administered, patient had the following side effects: hepatic encephalopathy. Emtriva dosage: . During the same period patient was treated with TENOFOVIR DISOPROXIL FUMARATE (View Tenofovir Disoproxil Fumarate Review and Tenofovir Disoproxil Fumarate Label ), SUSTIVA (View Sustiva Review and Sustiva Label ), COTRIM D.S. (View Cotrim D.s. Review and Cotrim D.s. Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ). Patient was hospitalized.

5146471-7 | Blood Bilirubin Increased, Granulomatous Liver Disease, Hepatic Enzyme Increased, Immune Reconstitution Syndrome, Macrophage Activation, Ocular Icterus, Oesophageal Candidiasis, Pyrexia
Patient was taking Emtriva (View Usage). Patient experienced the following unwanted or unexpected effects: blood bilirubin increased, granulomatous liver disease, hepatic enzyme increased, immune reconstitution syndrome, macrophage activation, ocular icterus, oesophageal candidiasis, pyrexia on Oct 27, 2006 from FRANCE Additional patient health information: Female patient , 32 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Emtriva dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), SUSTIVA (View Sustiva Review and Sustiva Label ), BACTRIM (View Bactrim Review and Bactrim Label ), ZECLAR (View Zeclar Review and Zeclar Label ), RIFAMPICIN (View Rifampicin Review and Rifampicin Label ), ETHAMBUTOL HYDROCHLORIDE (View Ethambutol Hydrochloride Review and Ethambutol Hydrochloride Label ). Patient was hospitalized.

5129764-9 | Blood Creatine Phosphokinase Increased, Hyperlactacidaemia, Monoparesis, Myositis, Oedema Peripheral
Adverse event was reported on Oct 09, 2006 by a Male patient taking Emtriva (View Usage) (Dosage: ) was diagnosed with candidiasis and. Location: UNITED KINGDOM , 50 years of age, weighting 143.3 lb, Patient had the following side effects: blood creatine phosphokinase increased, hyperlactacidaemia, monoparesis, myositis (What is myositis?), oedema peripheral. During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), RITONAVIR (View Ritonavir Review and Ritonavir Label ), FOSAMPRENAVIR (View Fosamprenavir Review and Fosamprenavir Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ). Patient was hospitalized.

5127991-8 | Arthralgia, Haemarthrosis, Haematospermia, Haematuria
on May 21, 2006 Male patient from JAPAN , 35 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtriva (View Usage). After Emtriva was administered, patient had the following side effects: arthralgia, haemarthrosis, haematospermia, haematuria. Emtriva dosage: . During the same period patient was treated with VIRAMUNE (View Viramune Review and Viramune Label ), RETROVIR (View Retrovir Review and Retrovir Label ), ALINAMIN F (View Alinamin-f Review and Alinamin-f Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ). Patient was hospitalized.

5083650-1 | Arthralgia, Chondropathy, Osteonecrosis
on May 22, 2006 Male patient from FRANCE , weighting 119.0 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Emtriva (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, chondropathy, osteonecrosis (What is osteonecrosis?). Emtriva dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), SUSTIVA (View Sustiva Review and Sustiva Label ). Patient was hospitalized.

5073505-0 | Abortion Induced, Blood Alkaline Phosphatase Increased, Bone Disorder, Hypophosphataemia, Pregnancy
Patient was taking Emtriva (View Usage). Patient had the following side effects: abortion induced, blood alkaline phosphatase increased, bone disorder, hypophosphataemia, pregnancy (What is pregnancy?) on Jul 27, 2006 from FRANCE Additional patient health information: Female patient , 40 years of age, weighting 147.7 lb, was diagnosed with acquired immunodeficiency syndrome and. Emtriva dosage: . During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), REYATAZ (View Reyataz Review and Reyataz Label ), SEROPRAM (View Seropram Review and Seropram Label ), LEXOMIL (View Lexomil Review and Lexomil Label ). Patient was hospitalized.